<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The incidence of <z:e sem="disease" ids="C0036527" disease_type="Neoplastic Process" abbrv="">ovarian metastases</z:e> at the time of <z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">peritoneal carcinomatosis</z:e>, and the influence of such <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> on survival after cytoreductive surgery (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRS</z:e>) and hyperthermic intraperitoneal chemotherapy (HIPEC), are unknown </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: This retrospective analysis included 194 women subjected to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRS</z:e> and HIPEC since 2001 </plain></SENT>
<SENT sid="2" pm="."><plain>The incidence of <z:e sem="disease" ids="C0036527" disease_type="Neoplastic Process" abbrv="">ovarian metastases</z:e>, disease-free survival and disease-specific survival were analysed </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The histological diagnosis was <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> <z:e sem="disease" ids="C0205699" disease_type="Neoplastic Process" abbrv="">carcinomatosis</z:e> in 108 patients, peritoneal mucinous <z:e sem="disease" ids="C0205699" disease_type="Neoplastic Process" abbrv="">carcinomatosis</z:e> (PMCA) in 23 and disseminated peritoneal adenomucinosis (DPAM) in 63 </plain></SENT>
<SENT sid="4" pm="."><plain>Ninety-nine patients underwent oophorectomy during the HIPEC procedure </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0036527" disease_type="Neoplastic Process" abbrv="">Ovarian metastases</z:e> were confirmed in at least 52 per cent of the patients </plain></SENT>
<SENT sid="6" pm="."><plain>There was a significant difference in disease-free survival between women with or without <z:e sem="disease" ids="C0036527" disease_type="Neoplastic Process" abbrv="">ovarian metastases</z:e> in both PMCA and DPAM groups (P = 0·044 and P = 0·010 respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>No significant differences in survival were found in the group with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> <z:e sem="disease" ids="C0205699" disease_type="Neoplastic Process" abbrv="">carcinomatosis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: When <z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">peritoneal carcinomatosis</z:e> of colorectal or appendiceal origin is confirmed, at least 52 per cent of ovaries will have synchronous <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Disease-free survival after a HIPEC procedure for PMCA or DPAM is significantly lower in women with <z:e sem="disease" ids="C0036527" disease_type="Neoplastic Process" abbrv="">ovarian metastases</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Oophorectomy during <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRS</z:e> for <z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">peritoneal carcinomatosis</z:e> should be strongly considered </plain></SENT>
</text></document>